Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, and Innovative Molecules GmbH (“Innovative Molecules”), a clinical-stage biotechnology company, today announced a strategic partnership ...

For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Rhian Brace shared her son Ernie's medical journey on Facebook One mom is speaking out about her baby’s medical ordeal to raise awareness. In a Facebook post that has received 3,000 likes and 1,200 ...

Medical researchers found a new way genetics influences the body's antiviral response by studying a life-threatening disease caused by a common virus: herpes simplex virus 1 (HSV-1). A collaboration ...

Herpes simplex virus (HSV1) infections are initiated at mucosal surfaces where the virus infects epithelial cells. When HSV1 spreads from the peripheral nerves and into the central nervous system, it ...

Outcomes of neonates with herpes simplex virus (HSV) encephalitis are worse after infection with HSV-2 when compared with HSV-1. The proteins herpes virus entry mediator (HVEM) and nectin-1 mediate ...

Herpes simplex virus causes the only viral encephalitis with an effective antiviral treatment; early treatment improves outcomes. Most cases in adults are caused by HSV-1 and occur equally in both ...

If you've ever been diagnosed with herpes simplex virus 2, the type of herpes that almost exclusively shows up on the genitalia, you might think to blame the partner who gave it to you, but they have ...

New research suggests that just one or two individual herpes virus particles attack a skin cell in the first stage of an outbreak, resulting in a bottleneck in which the infection may be vulnerable to ...